$12.3B SALES IN 2023
12.7% COMPOUND ANNUAL NON-GAAP EPS GROWTH RATE SINCE 1995
Our Q3 Results Reflect
- Our businesses performed well during the third quarter with growth and efficiency throughout the business driven by the successful implementation of our BOLD+1 Strategic Plan. We believe we continued to steadily gain market share in our dental and medical distribution business following last year’s cyber incident, and had a strong contribution from our high-growth, high-margin products and services.
- We are reporting another quarter exceeding our target of 40% of operating income generated by our high-growth, high-margin businesses, and we expect to exceed this target for fiscal 2024.
- Acquisitions made during our 2022 to 2024 strategic planning cycle, along with new product launches, are delivering strong financial results, and our restructuring plan is on target.
- We continue to return capital to shareholders through our share repurchase program.
At Henry Schein, Inc., our customers rely on us for an exceptional experience
Delivering differentiated solutions that make their practices more successful and improve patient outcomes. We are trusted advisors and consultants to our customers – enabling them to deliver the best quality patient care and enhance their practice management efficiency and profitability.
With more than 3,860 field sales consultants (including equipment sales specialists), approximately 1,950 telesales representatives, and more than 115 equipment sales and service centers worldwide, Henry Schein helps customers succeed by offering the products and services needed for delivering high-quality health care.
Stock Information
Security: (Common)
| Today's High | |
| Today's Low | |
| Volume |
Minimum 15 minutes delayed. Source: LSEG